(Stroke. 1995;26:1393-1398.)
© 1995 American Heart Association, Inc.
Articles |
Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke
From the Departments of Clinical Immunology (E.T., A.T.), Clinical Neurosciences (section of Neurology) (E.T., L.R., C.B., C.W.), Radiology (C.J., S.E.), and Rheumatology (A.T.), University of Göteborg, Sweden.
Correspondence to Dr Elisabeth Tarkowski, Department of Clinical Immunology, Guldhedsgatan 10, S-413 46 Göteborg, Sweden.
Background and Purpose We have previously demonstrated that stroke influences systemic immune responses. The aim of the present study was to investigate patterns of local inflammatory response as a consequence of acute stroke.
Methods Thirty stroke patients were studied prospectively on days 0 to 3, 7 to 9, 21 to 26, and after day 90 with clinical evaluations, radiological assessments, and analysis of serum and cerebrospinal fluid cytokine levels.
Results Significantly increased levels of interleukin-6 (IL-6) in
cerebrospinal fluid (P<.001) were observed in virtually all
patients studied compared with healthy control subjects. This increase
was observed during the whole observation period but was significantly
more pronounced within the first days after stroke onset, with a peak
level on days 2 and 3. This initial increase was significantly
correlated (r=.65, P=.002) with the volume of
infarct measured by MRI 2 to 3 months later. Serum levels of IL-6 in
stroke patients were significantly lower than cerebrospinal fluid
levels of IL-6 (P=.013) and did not display any significant
correlation to the size of the brain lesion. Also, increase in
intrathecal but not systemic production of IL-1ß
was observed early during the stroke. Only minor increases of
cerebrospinal fluid interferon-
levels were observed in two
patients.
Conclusions Our study demonstrates an intrathecal production of IL-6 and IL-1ß in patients with stroke, supporting the notion of localized inflammatory response to acute brain lesion. In addition, the significant correlation between early intrathecal production of IL-6 and the subsequent size of the brain lesion can be used as a prognostic tool, predicting the size of the brain damage before it is possible to accurately visualize it with radiological methods.
Key Words: cerebrospinal fluid • magnetic resonance imaging • interleukins • prognosis
This article has been cited by other articles:
 |
|
 |
|
  M. Abou-Ghazal, D. S. Yang, W. Qiao, C. Reina-Ortiz, J. Wei, L.-Y. Kong, G. N. Fuller, N. Hiraoka, W. Priebe, R. Sawaya, et al. The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas Clin. Cancer Res., December 15, 2008; 14(24): 8228 - 8235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Castellanos, T. Sobrino, S. Pedraza, O. Moldes, J. M. Pumar, Y. Silva, J. Serena, M. Garcia-Gil, J. Castillo, and A. Davalos High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke Neurology, December 2, 2008; 71(23): 1862 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Guldiken, S. Guldiken, B. Turgut, N. Turgut, M. Demir, Y. Celik, E. Arikan, and A. Tugrul The Roles of Oxidized Low-Density Lipoprotein and Interleukin-6 Levels in Acute Atherothrombotic and Lacunar Ischemic Stroke Angiology, May 1, 2008; 59(2): 224 - 229. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Spencer, A. Mouihate, and Q. J. Pittman Peripheral Inflammation Exacerbates Damage After Global Ischemia Independently of Temperature and Acute Brain Inflammation Stroke, May 1, 2007; 38(5): 1570 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Jefferson, J. M. Massaro, P. A. Wolf, S. Seshadri, R. Au, R. S. Vasan, M. G. Larson, J. B. Meigs, J. F. Keaney Jr, I. Lipinska, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study Neurology, March 27, 2007; 68(13): 1032 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Rantapaa-Dahlqvist, K Boman, A Tarkowski, and G Hallmans Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis Ann Rheum Dis, January 1, 2007; 66(1): 121 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yamada, N. Metoki, H. Yoshida, K. Satoh, S. Ichihara, K. Kato, T. Kameyama, K. Yokoi, H. Matsuo, T. Segawa, et al. Genetic Risk for Ischemic and Hemorrhagic Stroke Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1920 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cao, Y. Gao, J. B. Bryson, J. Hou, N. Chaudhry, M. Siddiq, J. Martinez, T. Spencer, J. Carmel, R. B. Hart, et al. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J. Neurosci., May 17, 2006; 26(20): 5565 - 5573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Samuelsson, E. Jennische, H.-A. Hansson, and A. Holmang Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABAA dysregulation and impaired spatial learning Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1345 - R1356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.-S. Shie, M. D. Neely, I. Maezawa, H. Wu, S. J. Olson, G. Jurgens, K. S. Montine, and T. J. Montine Oxidized Low-Density Lipoprotein Is Present in Astrocytes Surrounding Cerebral Infarcts and Stimulates Astrocyte Interleukin-6 Secretion Am. J. Pathol., April 1, 2004; 164(4): 1173 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Dziedzic, A Slowik, J Pera, and A Szczudlik Lack of association between interleukin-1{beta} polymorphism (-511) and ischaemic stroke J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 170 - 171. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lynch, R. Blessing, W. D. White, H. P. Grocott, M. F. Newman, and D. T. Laskowitz Novel Diagnostic Test for Acute Stroke Stroke, January 1, 2004; 35(1): 57 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dziedzic, A. Slowik, A. Szczudlik, M. Schwaninger, A. Grau, and D. Acalovschi Interleukin-6 and Stroke: Cerebral Ischemia Versus Nonspecific Factors Influencing Interleukin-6 * Response Stroke, December 1, 2003; 34 (12): e229 - e230. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Napoli and F. Papa Association Between Blood Pressure and C-Reactive Protein Levels in Acute Ischemic Stroke Hypertension, December 1, 2003; 42(6): 1117 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Acalovschi, T. Wiest, M. Hartmann, M. Farahmi, U. Mansmann, G. U. Auffarth, A. J. Grau, F. R. Green, C. Grond-Ginsbach, and M. Schwaninger Multiple Levels of Regulation of the Interleukin-6 System in Stroke Stroke, August 1, 2003; 34(8): 1864 - 1869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vila, J. Castillo, A. Davalos, A. Esteve, A. M. Planas, and A. Chamorro Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke Stroke, March 1, 2003; 34(3): 671 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Juttler, V. Tarabin, and M. Schwaninger Interleukin-6 (IL-6): A Possible Neuromodulator Induced by Neuronal Activity Neuroscientist, June 1, 2002; 8(3): 268 - 275. [Abstract] [PDF]
|
|
|
|
|
|
M. Castellanos, J. Castillo, M. M. Garcia, R. Leira, J. Serena, A. Chamorro, and A. Davalos Inflammation-Mediated Damage in Progressing Lacunar Infarctions: A Potential Therapeutic Target Stroke, April 1, 2002; 33(4): 982 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. BROADHURST and K. WILSON Immunology of delirium: new opportunities for treatment and research The British Journal of Psychiatry, October 1, 2001; 179(4): 288 - 289. [Full Text] [PDF]
|
|
|
|
|
|
N. Vila, J. Castillo, A. Davalos, and A. Chamorro Proinflammatory Cytokines and Early Neurological Worsening in Ischemic Stroke Stroke, October 1, 2000; 31(10): 2325 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Trysberg, H Carlsten, and A Tarkowski Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement Lupus, September 1, 2000; 9(7): 498 - 503. [Abstract] [PDF]
|
|
|
|
|
|
W. M. Clark, L. G. Rinker, N. S. Lessov, K. Hazel, J. K. Hill, M. Stenzel-Poore, F. Eckenstein, and E. C. Haley Jr Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System Ischemia Editorial Comment Stroke, July 1, 2000; 31(7): 1715 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Nellgard, G. B. Mackensen, G. Massey, R. D. Pearlstein, and D. S. Warner The Effects of Anesthetics on Stress Responses to Forebrain Ischemia and Reperfusion in the Rat Anesth. Analg., July 1, 2000; 91(1): 145 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kostulas, S. H. Pelidou, P. Kivisakk, V. Kostulas, and H. Link Increased IL-1{beta}, IL-8, and IL-17 mRNA Expression in Blood Mononuclear Cells Observed in a Prospective Ischemic Stroke Study Stroke, October 1, 1999; 30(10): 2174 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Davis and D. Barer Neuroprotection in acute ischaemic stroke. II: Clinical potential Vascular Medicine, August 1, 1999; 4(3): 149 - 163. [Abstract] [PDF]
|
|
|
|
|
|
E. Tarkowski, L. Rosengren, C. Blomstrand, C. Jensen, S. Ekholm, and A. Tarkowski Intrathecal Expression of Proteins Regulating Apoptosis in Acute Stroke Stroke, February 1, 1999; 30(2): 321 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pantoni, C. Sarti, and D. Inzitari Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 503 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. De Simoni, L. Terreni, R. Chiesa, F. Mangiarotti, and G. L. Forloni Interferon-{gamma} Potentiates Interleukin (IL)-6 and Tumor Necrosis Factor-{alpha} But Not IL-1{beta} Induced by Endotoxin in the Brain Endocrinology, December 1, 1997; 138(12): 5220 - 5226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chen, W. L. Castro, H.-H. Chow, and S. Reichlin Clearance of 125I-Labeled Interleukin-6 from Brain into Blood Following Intracerebroventricular Injection in Rats Endocrinology, November 1, 1997; 138(11): 4830 - 4836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martin-Ancel, A. Garcia-Alix, D. Pascual-Salcedo, F. Cabanas, M. Valcarce, and J. Quero Interleukin-6 in the Cerebrospinal Fluid After Perinatal Asphyxia Is Related to Early and Late Neurological Manifestations Pediatrics, November 1, 1997; 100(5): 789 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Heyser, E. Masliah, A. Samimi, I. L. Campbell, and L. H. Gold Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain PNAS, February 18, 1997; 94(4): 1500 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Kim, S. S. Yoon, Y. H. Kim, and J. S. Ryu Serial Measurement of Interleukin-6, Transforming Growth Factor-ß, and S-100 Protein in Patients With Acute Stroke Stroke, September 1, 1996; 27(9): 1553 - 1557. [Abstract] [Full Text]
|
|